Heart Failure Clinical Trial

Relationship Between LINQâ„¢ Subcutaneous Impedance and Right-sided Hemodynamic Measurements

Summary

The purpose of the ReLINQuish study is to characterize the relationship between subcutaneous impedance and hemodynamic measurements in patients with heart failure. Additionally, the relationship between changes in subcutaneous impedance and other physiologic parameters during acute decompensated HF events will be characterized.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients meeting at least 1 of 3 criteria will be included in the study:

Patients with symptomatic systolic or diastolic heart failure who in the clinician's judgment have a high likelihood of undergoing serial right heart catheterizations to aid in clinical management of their heart failure
Patients with dyspnea on exertion in whom exercise hemodynamics is indicated to diagnose diastolic dysfunction
Patients who have or will be implanted with a pulmonary artery pressure monitor
Patient is 18 years of age or older
Patient (or patient's legally authorized representative) is willing and able to provide written informed consent
Patient is willing and able to comply with the protocol, including follow-up visits and Carelink transmissions.

Exclusion Criteria:

Patient has an existing Medtronic implantable cardiac device
Patient has a left ventricular assist device (LVAD)
Patient is pregnant (all females of child-bearing potential must have a negative pregnancy test within 1 week of enrollment)
Patient is enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager

Study is for people with:

Heart Failure

Estimated Enrollment:

12

Study ID:

NCT03608826

Recruitment Status:

Completed

Sponsor:

Medtronic Cardiac Rhythm and Heart Failure

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Ohio State University
Columbus Ohio, 43210, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

12

Study ID:

NCT03608826

Recruitment Status:

Completed

Sponsor:


Medtronic Cardiac Rhythm and Heart Failure

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider